Solid lipid nanoparticles for targeted delivery of triclosan into skin for infection prevention

References

• Abdelbary, G. and Fahmy, R.H., 2009. Diazepam loaded solid lipid nanoparticles: design and characterisation. AAPS PharmSciTech, 10 (1),211–219.
   PubMed Web of Science ®Google Scholar
• Aljuffali, I.A., et al., 2014. Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. The AAPS journal, 16 (1),140–150.
   PubMed Web of Science ®Google Scholar
• Bhagwat, D.A., Kawtikwar, P.S., and Sakarkar, D.M., 2009. Formulation and the in vitro and biopharmaceutical evaluation of sustained release tablet of verapamil HCl using Precirol ATO 5 through melt granulation technique. Asian journal of pharmaceutics, 3 (4),278–285.
   Google Scholar
• Carter, L., et al., 2014. Fate and uptake of pharmaceuticals in soil-plant systems. Journal of agricultural and food chemistry, 62 (4),816–825.
   PubMed Web of Science ®Google Scholar
• Celebioglu, A., et al., 2014. Antibacterial electrospun nanofibers from triclosan/cyclodextrin inclusion complexes. Colloids and surfaces B biointerfaces, 116,612–619.
   PubMed Web of Science ®Google Scholar
• Cevc, G., 1997. Drug delivery across the skin. Expert opinion on investigational drugs, 6 (12),1887–1937.
   PubMedGoogle Scholar
• Chen, H., et al., 2006. Podophyllotoxin loaded solid lipid nanoparticles for epidermal targeting. Journal of controlled release, 110 (2),296–306.
   PubMed Web of Science ®Google Scholar
• Das, S., Ng, W.K., and Tan, R.B.H., 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterisations and comparative evaluations of clotrimazole loaded SLNs and NLCs? European journal of pharmaceutical sciences, 47 (1),139–151.
   PubMed Web of Science ®Google Scholar
• De Lissovoy, G., et al., 2009. Surgical site infection: Incidence and impact on hospital utilisation and treatment costs. American journal of infection control, 37 (5),387–397.
   PubMed Web of Science ®Google Scholar
• Dick, I.P. and Scott, R.C., 1992. Pig ear skin as an in-vitro model for human skin permeability. The journal of pharmacy and pharmacology, 44 (8),640–645.
   PubMed Web of Science ®Google Scholar
• Domínguez-Delgado, C.L., et al., 2011. Preparation and characterisation of triclosan nanoparticles intended to be used for the treatment of acne. European journal of pharmaceutics and biopharmaceutics, 79 (1),102–117.
   PubMed Web of Science ®Google Scholar
• Essa, S., Rabanel, J.M., and Hildgen, P., 2011. Characterisation of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethyleneglycol) grafting density. International journal of pharmaceutics, 411 (1–2),178–187.
   PubMed Web of Science ®Google Scholar
• Fagui, A., et al., 2013. Triclosan loaded with high encapsulation efficiency into PLA nanoparticles coated with? cyclodextrin polymer. Journal of inclusion phenomena and macrocyclic chemistry, 75 (3–4),277–283.
   Web of Science ®Google Scholar
• Flaten, G.E., et al., 2015. In vitro skin models as a tool in optimisation of drug formulation. European journal of pharmaceutical sciences, 75,10–24.
   PubMed Web of Science ®Google Scholar
• Godin, B. and Touitou, E., 2007. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Advanced drug delivery reviews, 59 (11),1152–1161.
   PubMed Web of Science ®Google Scholar
• Grice, E.A. and Segre, J.A., 2011. The skin microbiome. Nature reviews microbiology, 9 (4),244–253.
   PubMed Web of Science ®Google Scholar
• Gupta, M. and Vyas, S.P., 2012. Development, characterisation and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chemistry and physics of lipids, 165 (4),454–461.
   PubMed Web of Science ®Google Scholar
• Jenning, V. and Gohla, S., 2001. Encapsulation of retinoids in solid lipid nanoparticles (SLN). Journal of microencapsulation, 18 (2),149–158.
   PubMed Web of Science ®Google Scholar
• Josea, S., et al., 2014. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. International journal of pharmaceutics, 20 (1–2),6–13.
   Google Scholar
• Kamble, M.S., et al., 2012. Solid lipid nanoparticles and nanostructured lipid carriers - An overview. International journal of pharmaceutical, chemical and biological sciences, 2 (4),681–691.
   Google Scholar
• Kaur, A., Goindi, S., and Katare, O., 2016. Formulation, characterisation and in vivo evaluation of lipid based nanocarriers for topical delivery of diflunisal. Journal of microencapsulation, 33 (5),475–486.
   PubMed Web of Science ®Google Scholar
• Khezri, K., Dizaj, M.S., and Maleki, S., 2018. Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations. Biomedicine and pharmacotherapy, 106,1499–1505.
   PubMed Web of Science ®Google Scholar
• Kim, J.C., et al., 2002. Preparation and characterisation of triclosan containing vesicles. Colloids and surfaces B biointerfaces, 26 (3),235–241.
   Web of Science ®Google Scholar
• Kotikalapudi, L.S., et al., 2012. Formulation and in vitro characterisation of domperidone loaded solid lipid nanoparticles. International journal of pharmaceutical and biomedical research, 3 (1),22–29.
   Google Scholar
• Kupetz, E. and Bunjes, H., 2014. Lipid nanoparticles: drug localisation is substance specific and achievable load depends on the size and physical state of the particles. Journal of controlled release, 189,54–64.
   PubMed Web of Science ®Google Scholar
• Leaper, D., Fry, D., and Assadian, O., 2013. Perspectives in prevention and treatment of surgical site infection - a narrative review of the literature. Wounds: a compendium of clinical research and practice, 25 (11),313–323.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2007. Solid lipid nanoparticles loaded with insulin by sodium cholate phosphatidylcholine based mixed micelles: preparation and characterisation. International journal of pharmaceutics, 340 (1–2),153–162.
   PubMed Web of Science ®Google Scholar
• Mehnert, W., Mäder, K., and Wolfgang, M., 2001. Solid lipid nanoparticles production, characterisation and applications. Advanced drug delivery reviews, 47 (2–3),83–101.
   PubMed Web of Science ®Google Scholar
• Mu, H. and Holm, R., 2018. Solid lipid nanocarriers in drug delivery: characterization and design. Expert opinion on drug delivery, 15 (8),771–785.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Mäder, K., and Gohla, S.H., 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. European journal of pharmaceutics and biopharmaceutics, 50 (1),161–177.
   PubMed Web of Science ®Google Scholar
• Negi, J.S., et al., 2014. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self nanoemulsification (SNE) technique. Archives of pharmacal research, 37 (3),361–370.
   PubMed Web of Science ®Google Scholar
• Nerella, A., Basava, R., and Devi, A., 2014. Formulation, optimisation and in vitro characterisation of letrozole loaded solid lipid nanoparticles. International journal of pharmaceutical sciences and drug research, 6 (3),183–188.
   Google Scholar
• Patel, D., et al., 2012. Nanostructured lipid carriers (NLC) based gel for the topical delivery of aceclofenac: Preparation, characterisation, and in vivo evaluation. Scientia pharmaceutica, 80 (3),749–764.
   PubMedGoogle Scholar
• Patel, M.J., et al., 2010. Formulation and evaluation of self microemulsifying drug delivery system of lovastatin. Asian journal of pharmaceutical sciences, 5 (6),266–275.
   Google Scholar
• Quintanar-Guerrero, D., et al., 2005. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. European journal of pharmaceutical sciences, 26 (2),211–218.
   PubMed Web of Science ®Google Scholar
• Rahman, Z., Zidan, A.S., and Khan, M.A., 2010. Non destructive methods of charcaterisation of risperidone solid lipid nanoparticles. European journal of pharmaceutics and biopharmaceutics, 76 (1),127–137.
   PubMed Web of Science ®Google Scholar
• Rowe, R. C., et al., 2012. Diethylene glycol monoethyl ether. Handbook of pharmaceutical excipients. Washington, DC: Pharmaceutical Press,256–258.
   Google Scholar
• Sabu, C., et al., 2018. Bioinspired and biomimetic systems for advanced drug and gene delivery. Journal of controlled release, 287 (10),142–155.
   PubMedGoogle Scholar
• Schäfer-Korting, M., Mehnert, W., and Korting, H., 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Advanced drug delivery reviews, 59 (6),427–443.
   PubMed Web of Science ®Google Scholar
• Shah, B., et al., 2015. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterisation parameters. European journal of pharmaceutical sciences, 78,54–66.
   PubMed Web of Science ®Google Scholar
• Soares, S., et al., 2013. Effect of freeze drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles. International journal of pharmaceutics, 456 (2),370–381.
   PubMed Web of Science ®Google Scholar
• Suller, M.T. and Russell, A.D., 2000. Triclosan and antibiotic resistance in Staphylococcus aureus. Journal of antimicrobial chemotherapy, 46 (1),11–18.
   PubMed Web of Science ®Google Scholar
• Teichmann, A., et al., 2005. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. Journal of investigative dermatology, 125 (2),264–269.
   PubMed Web of Science ®Google Scholar
• Tupal, A., et al., 2016. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer. Journal of microencapsulation, 33 (4),372–380.
   PubMed Web of Science ®Google Scholar
• Vilela, R., Jácomo A.D., and Tresoldi, A.T., 2007. Risk factors for central venous catheter-related infections in paediatric intensive care. Clinical science, 62 (5),537–544.
   Google Scholar
• Westesen, K. and Bunjes, H., 1995. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? International journal of pharmaceutics, 115 (1), 129–131.
   Web of Science ®Google Scholar
• Wosicka, H. and Cal, K., 2010. Targeting to the hair follicles: current status and potential. Journal of dermatological science, 57 (2),83–89.
   PubMed Web of Science ®Google Scholar
• Yub, R.N., et al., 2014. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterisation, ex vivo, and in vivo assessment. International journal of pharmaceutics, 477,601–612.
   PubMed Web of Science ®Google Scholar